This suggests that while HER2 amplification and subsequent ERK activation does not engender MEK dependence, “second hits” in the pathway may be sufficient to overcome feedback suppression of signaling and elicit “output” from the MAPK pathway sufficient to drive tumor growth. The gene discussed is MAP2K7; the disease is neoplasm.